The Vein Clinic Of South Florida Inc is categorized under Surgeons in Pompano Beach, FL and active since 1987.
The Vein Clinic Of South Florida Inc was established in 1987, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Surgeons business, which does work in the B2C market, and is classified as a Surgeons, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact David A Dalessandro at the company’s single location by writing to 4040 Ne 31st Avenue, Pompano Beach, Florida FL 33064 or by phoning (303) 893-8888. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | The Vein Clinic Of South Florida Inc |
| Contact Person: | David A Dalessandro |
| Address: | 4040 Ne 31st Avenue, Pompano Beach, Florida 33064 |
| Phone Number: | (303) 893-8888 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 1987 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Surgeons |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
The Vein Clinic Of South Florida Inc was started in 1987 to provide professional Surgeons under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact David A Dalessandro for inquiries that concern The Vein Clinic Of South Florida Inc by calling the company number (303) 893-8888, as your correspondence is most welcome. Additionally, the physical location of the single location of The Vein Clinic Of South Florida Inc can be found at the coordinates as well as the street address 4040 Ne 31st Avenue in Pompano Beach, Florida 33064.
For its online presence, you may visit The Vein Clinic Of South Florida Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.